MHRA-102389-PIP01-26

Key Facts

Active Substance
Active Substance:
  • Humanised IgG4 monoclonal antibody against S100A4
Invented Name
Not available at present
PIP Number MHRA-102389-PIP01-26
Pharmaceutical form(s)
Pharmaceutical form(s):
  • All pharmaceutical form
Therapeutic area
Therapeutic area:
  • Pneumology - Allergology
Conditions / Indications
Conditions / Indications:
  • Treatment of idiopathic pulmonary fibrosis
Route(s) of administration
Route(s) of administration:
  • All routes of administration
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Humanised IgG4 monoclonal antibody against S100A4.pdf
Published Date 16/07/2026